Search

everythinglearnresearchcommunity

for

Search:↓

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Laser treatment can effectively reduce unwanted hair growth, particularly for people with fair skin and dark hair.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Adult female acne is complex and requires a combination of treatments for effective management.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Some women with PCOS have rare genetic variants linked to the condition.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Androgens can cause hair growth in some areas but hair loss on the scalp.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.